Backs FY24: Organic Net Revenue growth of 5% to 7%; Organic Net Revenue excluding Advocacy growth of 4% to 5%; Adjusted EBITDA of $400 million to $450 million; Free Cash Flow Conversion of approximately 50%.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks